| Ticker | GLUE |
|---|---|
| ISIN | US61225M1027 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, and breast cancers; NEK7 for the treatment of i...
El precio actual de Monte Rosa Therapeutics, Inc. (GLUE) es de 19,79 , con una variación del -1,88%.
Monte Rosa Therapeutics, Inc. opera en el sector Healthcare, industria Biotechnology.